The MiniMed™ 770G insulin pump system automatically adjusts background insulin every 5 minutes.* Using real-time glucose readings, the system is able to calculate a personalized amount of insulin to deliver based on your needs. The system connects directly with a compatible smartphone, allowing you to view sugar trends and insulin delivery on the go.
Customers using MiniMed™ 770G system now will have access to our future innovations.
Any customer using MiniMed™ 770G system will get access to our next technology, when available, at no cost through October 27, 2022.
Pump automatically adjusts background insulin every 5 minutes to help you stay in target range.*
See insulin delivery and sugar trends on your smartphone. Plus, receive high and low glucose alerts.
Enabled for future software upgrades, when such software upgrades are available. Customers will be offered a software upgrade at no charge through October 27, 2022.∆
Friends and family can view your sugar trends and insulin data on a smartphone.
Temporarily changes the glucose target to give you less insulin during activity.
Your pump and CGM data can now be automatically shared with your healthcare provider.*
The MiniMed™ 770G system is approved for people with type 1 diabetes ages 2 and above. To learn more about insulin pump therapy for children please click here. If you are considering using only an insulin pump, the MiniMed™ 630G system with optional CGM may be a better fit. If you are considering using only CGM, consider the Guardian™ Connect CGM system.
Yes. The MiniMed™ 770G system transmits data to your smartphone via wireless technology.
The MiniMed™ 770G system, sometimes referred to as a hybrid closed loop system, automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.* This integrated system – meaning having a pump and a CGM that speak to one another - may help reduce both high and low glucose levels.*
Every insurance company has different rules and processes, and at this time Medicare does not cover the CGM portion of the MiniMed™ 770G system. However, for those who meet certain criteria and would be interested in using CGM in the future, there may be options to allow you to purchase the MiniMed™ 770G pump with your insurance today.
Using the system does not completely replace fingersticks, but you will likely check your blood glucose (BG) less frequently than when using multiple daily injections. Readings from a blood glucose meter are required to calibrate the sensor 2-4 times a day to make sure the glucose sensor maintains accuracy over time and always when making a treatment decision.
When you use an insulin pump, you have a dramatic reduction in injections – by up to 90%*. The infusion set that attaches to your body contains a small, flexible cannula that is inserted to be placed under the skin and changed every 2-3 days. A CGM glucose sensor is inserted up to 7 days.
* Assumes four injections per day for 30 days and one infusion set change every two to three days.
The MiniMed™ 770G system offers advanced automation – known as SmartGuard™ Auto Mode. The system is also compatible with most smartphones, allowing you to view CGM and insulin data on the go.
1. To start your order, please fill out the form on this page. We’ll reach out to answer any questions you have, discuss out-of-pocket costs, and start the ordering process if you’d like to move forward.
2. Once the system is purchased and shipped, we will work with you to schedule your training. We have a robust clinical support team who can conduct training.
3. Once you’re trained, we will continue to support you throughout your journey with us. We will provide ongoing educational resources and also offer a dedicated Technical Support team who is available 24/7.
Check out this page for more info on insulin pump therapy.
The MiniMed™ 770G system is enabled for future software upgrades, when such software upgrades are available. Customers will be offered a software upgrade at no charge through October 27, 2022.∆
|Water Resistance||At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.|
|Environmental Conditions||The MiniMed™ 770G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump storage temperature range is from -4 °F (-20 °C) to 122 °F (50 °C). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi).|
|Insulin Type||Rapid-acting U100 insulin (Humalog® and NovoLog®) that has been prescribed by a healthcare professional.|
|Basal Rate Delivery||0 to 35 units per hour or the Max Basal Rate amount, whichever is lower.|
|Battery & Power||The pump requires one new AA (1.5 V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery.|
|Pump Memory||At any time you can review 90 days of pump history.|
|Size||The pump dimensions in inches are approximately 2.1 width x 3.78 length x 0.96 depth. The weight of the pump is approximately 3 ounces.|
|Reservoir||Medtronic reservoir MMT-332A, 3.0 ml (300-unit)|
|Infusion Sets||Medtronic Diabetes provides a variety of infusion sets to fit your needs.|
|Guardian™ Link 3 Transmitter||Used with your sensor for continuous glucose monitoring (CGM). This device connects to a glucose sensor. It collects data measured by the sensor and wirelessly sends this data to the pump.|
|Guardian™ Sensor 3||Used with your pump for CGM. The sensor is a small part of the continuous glucose monitoring system that you insert just below your skin to measure glucose levels in your interstitial fluid.|
|Accessories||Many accessories are available that can help you wear your pump in the way that's comfortable for you. See our collection of accessories here.|
|Accu-Chek® Guide Link Blood Glucose Meter||The MiniMed™ 770G system comes with a compatible meter. Accurate test results are sent wirelessly to the pump for quick sensor calibration.|
* Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.
** Automated sharing available when linked to healthcare provider's account.
∆ Program eligibility requirements and terms and conditions apply. Subject to change.
Software Upgrade Terms and Conditions:
Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.
The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library